Health News Releases

August 08, 2013 17:27

Cochlear Announces the Nucleus(R) 6 System - Simply Smarter in Every Hearing Situation

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has announced CE mark approval for Nucleus 6, its next generation cochlear implant sound processor. Nucleus 6 delive

July 28, 2013 12:21

CereSpir Incorporated Announces Letter of Intent With Chiesi Farmaceutici SpA, to License Worldwide Development and Commercialization Rights for CHF 5074 to CereSpir

CereSpir™ Incorporated and Chiesi Farmaceutici S.p.A. today acknowledged the Companies have entered into a Letter of Intent and are negotiating a Licensing Agreement, whereby CereSpir will acquire the

July 24, 2013 13:03

Daeyang Medical Co. LTD, Launches ‘VinuShape’: Beauty Instrument with Optimal Efficiency According to Target Area and Use

Earlier this month, Daeyang Medical Co. LTD, a specialized company for aesthetic &physical therapy devices (CEO Minjeong Yoon), launched the beauty instrument ‘VinuShape’, effective for body shape and

July 17, 2013 17:02

Invivoscribe FLT3 Method Patent Claims Upheld

Invivoscribe Technologies, Inc. (“Invivoscribe”) has successfully defended the method claims at the core of international patents covering FLT3 internal tandem duplication (FLT3 ITD) mutation testing.

July 09, 2013 16:14

KOSTEC, seeks penetration into the Chinese medical monitor market through its exclusive distributor agreement with RABO

Representative Kwon Oh Sung of KOSTEC, a medical special-purpose monitor specialized-company located in Wonju, Kangwondo (CEO Kwon Oh Sung, www.n-kostec.co.kr) has stated “In recent years, we've signe

July 09, 2013 14:13

KOSTEC, distinguished company in domestic and overseas medical monitor equipment market

KOSTEC(CEO Kwon Oh-sung, www.n-kostec.co.kr), a specialized company for medical-purpose monitors, successfully concluded contracts in domestic and oversease companies. Domestics Sales team manager

July 08, 2013 11:02

Medical Tourism Association(R)-University of Miami Partnership Offering First Continuing Education Credits in Medical Tourism

Forward-thinking healthcare professionals can maintain competence and expand knowledge of policies and practices related to patients seeking medical tourism opportunities by earning up to 11 Continuin

July 02, 2013 17:36

BT Inc. participates in INACSL 2013 for the first time in Korea, using medical training simulators

Medical training simulator specializing company BT Inc.(CEO Yang Seung Jin/Park Yong Ki, www.btinc.co.kr) attended the ‘INACSL 2013 (International Nursing Association for Clinical Simulation and Learn

July 02, 2013 15:40

Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells

Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem c

July 02, 2013 10:15

i-SENS, selected for ‘World Class 300’

Biomedical device specialized company i-SENS(Representative Geun Sig Cha) has been selected as one of the ‘World Class 300’ companies, reported on May 9th. ‘World Class 300’ selects small and mediu

June 28, 2013 10:47

N-Care introduces NP-20 for first time at the ‘2013 Busan International Anti-aging Expo’

Han Seung-beom, the President of N-care. Inc. Ltd. which specialises in medical devices, announced that they will attend the “2013 Busan International Silver Expo” which will be held in Bexco from the

June 27, 2013 09:24

Biohit to Establish Joint Venture in China - Biohit Biotech(Hefei)

Finnish healthcare company Biohit Oyj has agreed to set up a Joint Venture company in China. The Chinese partner to the Joint Venture is Anhui Wisdom-Win Investment Co., Ltd. Official name of the Join

June 26, 2013 17:53

Medical Tourism Association(R) Expands News Website to Heighten Healthcare Awareness, Encourage Patient Engagement

Patients might be tempted to go to any length of the earth to gain access to information that would help them lead a more healthier and productive life if they didn't have it at their finger tips alre

June 26, 2013 15:13

Nanobiotix Announces the Selection of its Second NanoXray Product, NBTX-IV and a Collaboration with the National Cancer Institute for Development

NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces the selection of a new product for development, NBTX-IV. It

June 24, 2013 16:21

IncellDx Signs Deal With GeneCell Diagnostics to Offer New HPV Technology in India

IncellDx announced today that it has reached an agreement to offer its proprietary laboratory test for the detection of oncogenic HPV E6, E7 mRNA in India. The agreement with GeneCell Diagnostics Pvt.

June 24, 2013 10:20

Invivoscribe FLT3 Testing Patents Strengthened by Supreme Court Ruling

In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the diagnostic community to note that the limits of the Myri

June 17, 2013 09:51

Mayapada Hospital South Jakarta Performs its First Laparoscopic Surgery

Mayapada Hospital South Jakarta performed its first ever laparoscopic surgery to remove fibroids from a woman's body on Wednesday, June 12th. The successful surgery was performed by a team of medical

June 14, 2013 12:00

First Guidelines for Treating Non-Transfusion-Dependent Thalassaemia Introduced at European Haematology Association Meeting

New guidelines released by the Thalassaemia International Federation (TIF) address the Management of Non-Transfusion Dependent Thalassaemias (NTDT) and are a first of their kind in the field of medica

June 13, 2013 15:10

Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with Lead Product NBTXR3

NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that its lead compound NBTXR3 has received authorizati

June 13, 2013 09:28

IncellDx Signs Deal With Kindstar Global to Offer Novel HPV Technology in China for Cervical Cancer Screening

IncellDx announced today that it has executed an agreement with Kindstar Global, the largest esoteric diagnostic testing service in China, to offer its proprietary laboratory test for the detection of

June 12, 2013 09:32

CanChew Biotechnologies Shipping Large-Scale Product Orders -- Expands Into Wholesale and Distributor Sales of Its CanChew CBD Gum

CanChew Biotechnologies, a Medical Marijuana Inc. (OTC:MJNA) joint venture company, is excited to announce its wholly owned subsidiary CannaGum Marketing Group has opened a new warehouse for CanChew C

June 11, 2013 17:46

Harmony(TM) Prenatal Test Demonstrates Clinical Utility in a General Screening Population

The Harris Birthright Centre for Fetal Medicine today released results from a clinical implementation study (http://onlinelibrary.wiley.com/doi/10.1002/uog.12504/full) on the use of Ariosa Diagnostics

June 04, 2013 15:10

Nanobiotix's NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma

NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces positive Phase I interim results of its lead nanoparticle-ba

June 03, 2013 14:45

Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class

Primary end-point results from the BIOFLOW-II Clinical Study demonstrating the non-inferiority of the BIOTRONIK Orsiro Hybrid Drug-Eluting Stent compared to Abbott's XIENCE PRIME™. These results were

May 24, 2013 14:08

BIOTRONIK Announces Completion of Enrollment in IMPACT Study to Investigate Stroke Risk Reduction in Patients With Atrial Fibrillation

BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed for the highly anticipated IMPACT study. The study aims to investigate whether th

News by Region

News by Industry